TABLE 3

Study outcome events in patients in different risk categories according to 2014 and 2008 European Society of Cardiology (ESC) models

RiskESC 2014ESC 2008
sPESIRVD or increased troponinDeath at 30 daysDeath due to pulmonary embolismRVD or increased troponinDeath at 30 daysDeath due to pulmonary embolism
High#≥123/105
(22, 14.0–29.8)
16/105
(15.2, 8.4–22.1)
23/105
(22, 14.0–29.8)
16/105
(15.2, 8.4–22.1)
Intermediate-high≥1Both present21/272
(7.7, 4.5–10.9)
13/272
(4.8, 2.2–7.3)
Both present21/307
(6.8, 4.0–9.7)
13/307
(4.2, 2.0–6.5)
Intermediate-low≥1Either present or both absent20/333
(6.0, 3.4–8.6)
7/333
(2.1, 0.6–3.6)
Either present19/271
(7.0, 4.0–10.0)
8/271
(3.0, 0.9–5.0)
Low01/196
(0.5, 0–1.5)
1/196
(0.5, 0–1.5)
Both absent2/223
(0.9, 0–2.1)
0/223
(–, –)
  • Data are presented as n/N (%, 95% CI). RVD: right ventricle dysfunction. #: shock or sustained hypotension.